Dr. Michael Mauro speaks after the ASH 2015 conference about CML, where we are, and where we are going, together with some brief detail of AML 001 a "4th Generation" inhibitor. Good interesting watch and info. ( you may need to log in, but can do this though a Facebook account if you have one rather than setting one up with patient power )
http://www.patientpower.info/video/an-expert-s-review-of-cml-ash-news/?a...
l